Guggenheim Capital LLC Bridge Bio Pharma, Inc. Transaction History
Guggenheim Capital LLC
- $12 Billion
- Q4 2024
A detailed history of Guggenheim Capital LLC transactions in Bridge Bio Pharma, Inc. stock. As of the latest transaction made, Guggenheim Capital LLC holds 44,661 shares of BBIO stock, worth $1.56 Million. This represents 0.01% of its overall portfolio holdings.
Number of Shares
44,661
Previous 51,001
12.43%
Holding current value
$1.56 Million
Previous $1.3 Million
5.62%
% of portfolio
0.01%
Previous 0.01%
Shares
9 transactions
Others Institutions Holding BBIO
# of Institutions
315Shares Held
177MCall Options Held
11.2MPut Options Held
2.29M-
Kohlberg Kravis Roberts & Co. L.P. New York, NY25.3MShares$882 Million44.98% of portfolio
-
Viking Global Investors LP25.1MShares$877 Million2.33% of portfolio
-
Vanguard Group Inc Valley Forge, PA15.1MShares$526 Million0.01% of portfolio
-
Black Rock Inc. New York, NY12.4MShares$434 Million0.01% of portfolio
-
State Street Corp Boston, MA6.18MShares$216 Million0.01% of portfolio
About BridgeBio Pharma, Inc.
- Ticker BBIO
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 148,246,000
- Market Cap $5.17B
- Description
- BridgeBio Pharma, Inc. engages in the discovery, development, and delivery of various medicines for genetic diseases. The company has a pipeline of 30 development programs that include product candidates ranging from early discovery to late-stage development. Its products in development programs include AG10 and BBP-265, a small molecule stabili...